Saba Capital Management’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3K Hold
243,249
﹤0.01% 355
2025
Q4
$21.6K Hold
243,249
﹤0.01% 294
2025
Q3
$4.94K Hold
243,249
﹤0.01% 304
2025
Q2
$11.4K Hold
243,249
﹤0.01% 283
2025
Q1
$11.1K Hold
243,249
﹤0.01% 224
2024
Q4
$12.1K Hold
243,249
﹤0.01% 243
2024
Q3
$14.4K Hold
243,249
﹤0.01% 273
2024
Q2
$52.6K Sell
243,249
-7,600
-3% -$1.15K ﹤0.01% 237
2024
Q1
$37.4K Hold
250,849
﹤0.01% 267
2023
Q4
$6.54K Hold
250,849
﹤0.01% 426
2023
Q3
$5.54K Hold
250,849
﹤0.01% 524
2023
Q2
$16.7K Hold
250,849
﹤0.01% 507
2023
Q1
$21.3K Hold
250,849
﹤0.01% 625
2022
Q4
$24.8K Hold
250,849
﹤0.01% 717
2022
Q3
$32K Hold
250,849
﹤0.01% 900
2022
Q2
$26K Hold
250,849
﹤0.01% 970
2022
Q1
$37K Sell
250,849
-120,160
-32% -$28.1K ﹤0.01% 895
2021
Q4
$145K Buy
+371,009
New +$145K ﹤0.01% 685

Other funds holding VSEEW

Saba Capital Management's VSEEW Position: Q1 2026 in Review

Saba Capital Management held its VSEE HEALTH INC WTS 29 (VSEEW) position steady in Q1 2026 at 243,249 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

Saba Capital Management first reported a position in VSEEW in Q4 2021 and has held it in 18 quarters since. The position peaked at $145K in Q4 2021. 19 funds tracked by Wall St. Rank hold VSEEW as of Q1 2026.

  • Saba Capital Management held 243,249 shares of VSEE HEALTH INC WTS 29 worth $10.3K as of Q1 2026.
  • Saba Capital Management left its VSEE HEALTH INC WTS 29 share count unchanged in Q1 2026.
  • VSEE HEALTH INC WTS 29 made up ﹤0.01% of Saba Capital Management's portfolio in Q1 2026, its #355 holding.
  • Saba Capital Management first reported a position in VSEE HEALTH INC WTS 29 in Q4 2021 and has held it in 18 quarters since.
  • Saba Capital Management's VSEE HEALTH INC WTS 29 position peaked at $145K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q1 2026.

Based on Saba Capital Management's 13F filing for Q1 2026, filed 15 May 2026.